Stability of tuberous sclerosis complex 2 is controlled by methylation at R1457 and R1459

Seishu Gen1, Yu Matsumoto1, Ken-Ichi Kobayashi1

  • 1Laboratory of Nutritional Biochemistry, Department of Agricultural Chemistry, Faculty of Applied Bioscience, Tokyo University of Agriculture, 1-1-1 Sakuragaoka, Setagaya-ku, Tokyo, 156-8502, Japan.

Scientific Reports
|December 4, 2020
PubMed

Insights

Tuberous sclerosis complex 2 (TSC2) stability is regulated by novel methylation. Protein arginine methyltransferase 1 (PRMT1) methylates TSC2, impacting its phosphorylation and stability, crucial for cell growth regulation.

Area of Science:

  • Molecular Biology
  • Cellular Biology
  • Biochemistry

Background:

  • Tuberous sclerosis complex 2 (TSC2) mutations cause tuberous sclerosis complex disease.
  • TSC2 forms a complex with TSC1 to inhibit cell growth by inactivating mTORC1.
  • TSC2 activity is primarily regulated by phosphorylation, but other mechanisms exist.

Purpose of the Study:

  • To investigate novel posttranslational modifications regulating TSC2.
  • To identify the specific methylation sites and the enzyme responsible for TSC2 methylation.
  • To determine the functional impact of TSC2 methylation on its stability and activity.

Main Methods:

  • Mass spectrometry to identify methylation sites.
  • Site-directed mutagenesis to alter specific arginine residues.
  • Western blotting to assess protein levels and phosphorylation status.
  • Co-immunoprecipitation assays to study protein interactions.

Main Results:

  • TSC2 is methylated at arginine residues R1457 and R1459 by PRMT1.
  • PRMT1-mediated methylation affects TSC2 phosphorylation at T1462 by Akt.
  • Methylation at R1457 and R1459 is essential for TSC2 protein stability.
  • This methylation pathway influences the TSC2-TSC1 complex activity.

Conclusions:

  • PRMT1-mediated methylation represents a novel regulatory mechanism for TSC2.
  • Methylation is critical for maintaining TSC2 stability and proper cellular function.
  • These findings reveal a new layer of posttranslational control over the TSC2 pathway, impacting tuberous sclerosis complex disease.

Related Concept Videos

Microtubule Instability02:17

Microtubule Instability

Microtubules are hollow cylindrical filaments having a diameter of approximately 25 nm and a length that varies from 200 nm to 25 μm. GTP-bound tubulin subunits form αβ-heterodimers for microtubule assembly. These core building blocks interact longitudinally, polymerizing into protofilaments. The protofilaments then interact with one another through lateral bonding forces to form stable cylindrical microtubules. These cylindrical filaments are dynamic as they undergo repeated...
5.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.9K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
8.2K
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
6.2K